Efficacy and safety of HAT1 compared with calcipotriol in the treatment of patients with mild to moderate chronic plaque psoriasis: results from an open‐label randomized comparative pilot clinical study

Psoriasis is commonly treated with topical corticosteroids, oral cytotoxic drugs and biologic agents, which can be associated with significant adverse effects (AEs), high cost and response attenuation. Additionally, patients often use alternative therapies ad hoc, which can be challenging to integra...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Exp Dermatol
Hoofdauteurs: Alex, P., Williams, S., Sutton, L., Yesudas, T., Sutton, C., Thomas, S., Centola, M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Concise Reports
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154690/
https://ncbi.nlm.nih.gov/pubmed/31419323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ced.14074
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items